Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis

Authors:

Abstract
Atopic dermatitis (AD) is a common chronic inflammatory skin disease, characterized by eczematous morphology and intense pruritus.1,2 The age of onset of AD is variable and can occur at any point in life, with the highest incidence of onset in childhood.2,3 Prevalence of AD is estimated at 20% in children, with 10% to 20% of cases persisting into adolescence, during which prevalence rates range from 5% to 20%, varying based on geographic location.3-5 Adolescents with AD experience impacts to quality of life that are shared with other age groups, like increased reports of depression and anxiety. Given the importance of psychosocial development during adolescence, AD also impacts identity, relationship building, self-esteem, and school performance.2,6-8 Further, development of autonomy and independence during adolescence can impact adherence and risk-taking behaviors that can challenge treatment plans. Additionally, there are reports of increased suicidal behavior in adolescents with AD.9 Given its negative impacts to adolescent quality of life, there remains a need for treatments available to this population.

This publication has 22 references indexed in Scilit: